Articles by Richard B. Hancock - BioPharm International

Articles by Richard B. Hancock

Plasmid DNA–Based Vaccines: Combating Infectious Diseases

A comparison of plasmid DNA-based vaccines with vaccines developed from egg and cell-based methods
Aug 2, 2007
By: Richard B. Hancock, Melissa M. Rosness

Like the egg-based vaccine production process, producing a vaccine under cGMP conditions using mammalian cells can be a lengthy process, taking a minimum of six to 12 months.